- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2017
- Public Summary Document (PSD) March 2017 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2017 PBAC Meeting - Word
Nivolumab – March 2017
Nivolumab: Injection concentrate for I.V. infusion 40 mg in 4 mL and 100 mg in 10 mL; Opdivo®
Last updated
30 June 2017